← Leaderboards
Tae Woo Park
Boston Medical Center
$926,892
Attributed
$926,892
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $188.5K · FY2017–21$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$926,892 · 1
By mechanism
K23$926,892 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Medical Center
Same institution · by research overlap
- Judith Tsui$9,934,962
- Elisha Wachman$6,271,367
- Caroline J Kistin$3,458,626
- Karsten Lunze$5,048,816
- Joshua Adam Barocas$5,317,959
Others in their field
Other Emerging Leaders on “Esthesia”
- Barbara Halina Braffett · George Washington University$10,066,665
- Ionut Bebu · George Washington University$10,066,665
- Fritzie Isip Arce-McShane · University Of Chicago$8,230,803
- Lee E Fisher · University Of Pittsburgh At Pittsburgh$6,758,634
- Kathleen E Cullen · Jackson Laboratory$5,384,461
- Stephen Blumberg · National Institute On Deafness And Other Communication Disorders$4,725,000
Research focus
EsthesiaAbstinenceAnxietyEmotionalAnxiety SensitivityAnxiety TreatmentBaseBehavioralBehavioral PharmacologyAddictionBenzodiazepinesBostonBuprenorphineCareerClinical InvestigatorCognitiveCravingDisorder Later Incidence PreventionDistressDistress ToleranceDrug AbuseEffective TherapyElementsEuphoria
Grant awards (6)
Distress Tolerance and Benzodiazepine Discontinuation in Opioid Agonist Therapy$163,999
K23 · FY2021 · DA · contact PI
Distress Tolerance and Benzodiazepine Discontinuation in Opioid Agonist Therapy$15,459
K23 · FY2021 · DA · contact PI
Distress Tolerance and Benzodiazepine Discontinuation in Opioid Agonist Therapy$187,475
K23 · FY2020 · DA · contact PI
Distress Tolerance and Benzodiazepine Discontinuation in Opioid Agonist Therapy$188,469
K23 · FY2019 · DA · contact PI
Distress Tolerance and Benzodiazepine Discontinuation in Opioid Agonist Therapy$185,850
K23 · FY2018 · DA · contact PI
Distress Tolerance and Benzodiazepine Discontinuation in Opioid Agonist Therapy$185,640
K23 · FY2017 · DA · contact PI